Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy

This study has been completed.
Information provided by (Responsible Party):
Swiss Group for Clinical Cancer Research Identifier:
First received: September 13, 2012
Last updated: July 25, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2016
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)